1. Market Research
  2. > Therapy
4 reports for Salicylic Acid (page 1)

Purchase Reports From Reputable Market Research Publishers

Drug of Abuse Testing Market (By Product Type, Sample/Test Type, End Users / Setting Type, Region), Regulatory Status, 20 Company Profiles – Global Forecast to 2025

  • $ 1990
  • January 2020
  • 150 pages

Opiate Oxycodone Phencyclidine Propoxyphene Salicylate Synthetic Cannabinoid K-##/ K-## (Restricted in the U. S. to law enforcement related use (forensic use only)).

  • Diagnostics
  • Drug Testing
  • Salicylic Acid
  • World
  • Forecast

Global Drug of Abuse Testing Market (By Product Type, Sample/Test Type, End Users / Setting Type, Region), Regulatory Status, 20 Company Profile – Forecast to 2024

  • $ 1600
  • October 2018
  • 142 pages

Medical tests for toxicology and drugs of abuse are usually done as a panel on overdose and trauma patients brought into emergency and include: a screen for alcohol, acetaminophen, salicylates, tricyclic antidepressants and individual tests for amitriptyline, amphetamines, barbiturates, ben

  • Drug Testing
  • Laboratory
  • Salicylic Acid
  • World
  • Forecast

United States IVD Market (By Application Segments, Products, Region, End Users) Size, Share, Major Deals & Company Analysis - Forecast to 2025

  • $ 1990
  • September 2019
  • 201 pages

The intensive investigation of coagulation processes has uncovered a number of other conditions in which coagulation factors are implicated, such as: post-surgical bleeding due to the use of aspirin or Plavix, spontaneous abortion and pregnancy problems.

  • Diagnostics
  • In Vitro Diagnostics
  • Salicylic Acid
  • North America
  • United States

Global Biosimilars Market and Forecast (By Product Type, Applications, Country Wise and Companies) to 2021 and Biosimilars Approved and Pipeline Analysis

  • $ 1350
  • October 2016
  • 177 pages

For example, aspirin, part of a common category of medicine known as small-molecule drugs, is made of up only ## atoms.

  • Biopharmaceutical
  • Biosimilar
  • Medical Biotechnology
  • Pharmaceutical
  • Salicylic Acid


View report >

Hospital Social Impact in Texas (USA)

  • January 2019
  • 70 pages

OF ##, ## MI CASES SEEN BETWEEN 2008 AND 2018, ##. ##% WERE PRESCRIBED ASPIRIN WITHIN THE FIRST ## HOURS OF EITHER FIRST MEDICAL CONTACT OR HOSPITAL ARRIVAL, ##. ##% WERE NOT PRESCRIBED ASPIRIN, AND ##. ##% HAD CONTRAINDICATIONS TO ASPIRIN USE (PG. ##).

  • Health Services
  • Heart Attack
  • Hospital
  • Salicylic Acid
  • United States

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on